Brief Description
Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders. The molecular engineering company was spun out of discoveries in the lab of UC Berkeley Professor of Biochemistry, Biophysics and Structural Biology and Nobel Laureate Jennifer Doudna. Doudna co-founded Scribe with company CEO Benjamin Oakes, who received a PhD in Molecular and Cellular Biology from UC Berkeley in 2017, where he worked in the Doudna Lab and Savage Lab, UC Berkeley Associate Professor of Biochemistry, Biophysics, and Structural biology David Savage, and former Doudna postdoc Brett Staahl.
Timeline
- 2018. Company founded
Inventors
Jennifer Doudna, David Burstein, Jillian Banfield, Lucas Harrington, Steven Strutt